Immune Cell Response to Stimuli
NCT00397280 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 750
Last updated 2026-05-22
Summary
This study will investigate the response of immune cells (neutrophils, monocytes) to various signals in the test tube to determine how they sense the signals in the body and what substances they produce in response to them. It will determine how the cells may, under certain circumstances, contribute to inflammation, and will measure substances in the blood plasma (the liquid, non-cellular part of the blood) that might stimulate white blood cells, in order to understand how the blood responds to possible disease-related conditions.
Healthy normal volunteers 18 years of age and older who weigh at least 110 pounds may be eligible for this study. Participants give about 320 milliliters (mL) of blood (about 1 1/3 cups) or less at each donation. They donate no more than once every 8 weeks and no more than six times a year. On some occasions, less than 320 mL of blood may be drawn. The collected blood is separated into its components and specific cells are exposed to substances to examine their response....
Conditions
Sponsors & Collaborators
-
National Institute of Environmental Health Sciences (NIEHS)
lead NIH
Principal Investigators
-
Michael B Fessler, M.D. · National Institute of Environmental Health Sciences (NIEHS)
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-07-13
Countries
- United States
Study Locations
More Related Trials
-
COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics
NCT04871932 ·Status: RECRUITING
-
CD8 Reactivity to Microorganisms in Blood and Breast Milk
NCT03084614 ·Status: TERMINATED
-
Determining the Amount of Time Needed for Nelfinavir to Boost the Immune System in Adults
NCT00346619 ·Status: COMPLETED ·Phase: PHASE1
-
Natural Killer Cells Functions, Tumoral Escape to Immune System and Regulation of Natural Cytotoxixity Receptors in Haematological Malignancies
NCT01915992 ·Status: UNKNOWN ·Phase: NA
-
T Cells Response to SARS COV 2 Peptides
NCT04573348 ·Status: UNKNOWN
-
Blood Sampling of Healthy Volunteers for Immunological Research
NCT03819829 ·Status: RECRUITING ·Phase: NA
-
Prospective Study of White Blood Cells
NCT04838171 ·Status: RECRUITING
-
Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy
NCT06089967 ·Status: COMPLETED
-
Understanding COVID-19 Vaccine Immunity in Tissue and Blood
NCT05682625 ·Status: WITHDRAWN
-
Development of a Cell Culture Process for the Production of Human T-lymphocyte Precursors
NCT05118113 ·Status: UNKNOWN ·Phase: NA
-
A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19
NCT04324996 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes
NCT00327236 ·Status: COMPLETED
-
VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
NCT01132859 ·Status: RECRUITING
-
In Vitro Studies of Immunological and Stem Cell Function in Peripheral Blood Mononuclear Cells in Patients
NCT00001336 ·Status: COMPLETED
-
Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects
NCT04408950 ·Status: COMPLETED
-
Immune Response to the COVID-19 Vaccine
NCT04936997 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Collection of Data and Samples From Healthy Donors for Use in Translational Research
NCT00090662 ·Status: RECRUITING
-
The COX-2 Gene and the Immune System
NCT01678222 ·Status: COMPLETED
-
Tai-Chi-Chuan on Differentiation and Maturation of Dendritic Cells
NCT00322959 ·Status: COMPLETED
-
A Therapeutic Protocol in Previous Failed ART Patients With High Total NK Cells
NCT03792997 ·Status: COMPLETED ·Phase: PHASE2
-
Immunity to Infection in Healthy Participants and Participants With Cancer
NCT05787964 ·Status: ACTIVE_NOT_RECRUITING
-
Polyinosinic-Polycytidylic Acid-poly-L-lysine Carboxymethylcellulose (Poly-ICLC) in Healthy Volunteers
NCT01299662 ·Status: COMPLETED ·Phase: PHASE1
-
Predictive Markers of Immune-related Adverse Events in Patients Treated With Immune Stimulatory Drugs
NCT03984318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors
NCT00576537 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-Pseudomonas Immune Status and Dendritic Cell Preparation in Normal Individuals
NCT00320164 ·Status: COMPLETED